Mycobacterium avium complex pulmonary disease. Risk factors

被引：0
|
作者：
Tabernero Huguet, E. [1 ]
Altube, L. [2 ]
Garcia Fuertes, J. A. [3 ]
Leal Arranz, M. V. [4 ]
Ugedo Urruela, J. [5 ]
Ortiz Laza, N. [1 ]
Ortiz De Urbina, B. [1 ]
Rezola Carasusan, A. [1 ]
Gomez Larrauri, A. [1 ]
Garcia Echeberria, L. [1 ]
Santos Zorrozua, B. [6 ]
机构：
[1] Hosp Cruces, Bilbao, Bizkaia, Spain
[2] Hosp Galdakao, Galdakao, Bizkaia, Spain
[3] Hosp Univ Araba, Vitoria, Alava, Spain
[4] Hosp Basurto, Bilbao, Bizkaia, Spain
[5] Hosp San Pedro, Logrono, La Rioja, Spain
[6] Biocruces, Bilbao, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Environment; Bronchiectasis; Adults;
D O I：
10.1183/13993003.congress-2022.3246
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3246
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Predictive risk factors of treatment-refractory Mycobacterium avium complex lung disease
    Saito, Takahiko
    Aono, Yuya
    Kono, Masato
    Sugiura, Takuma
    Higasa, Misato
    Katsumata, Mineo
    Miwa, Hideki
    Miki, Yoshihiro
    Hashimoto, Dai
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [42] Risk Factors for Recurrence after Successful Treatment of Mycobacterium avium Complex Lung Disease
    Lee, Bo Young
    Kim, Sunyoung
    Hong, YoonKi
    Lee, Sang-Do
    Kim, Woo Sung
    Kim, Dong Soon
    Shim, Tae Sun
    Jo, Kyung-Wook
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 2972 - 2977
  • [43] Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease
    Kobashi, Yoshihiro
    Fukuda, Minoru
    Yoshida, Kouichiro
    Miyashita, Naoyuki
    Niki, Yoshihito
    Oka, Mikio
    RESPIROLOGY, 2006, 11 (06) : 809 - 813
  • [44] RISK STRATIFICATION FOR THE DEVELOPMENT OF CHRONIC PULMONARY ASPERGILLOSIS IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE
    Furuuchi, Koji
    Ito, Akihiro
    Hashimoto, Toru
    Kumagai, Shogo
    Ishida, Tadashi
    RESPIROLOGY, 2017, 22 : 19 - 20
  • [45] Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease
    Furuuchi, Koji
    Ito, Akihiro
    Hashimoto, Toru
    Kumagai, Shogo
    Ishida, Tadashi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (08) : 654 - 659
  • [46] Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
    Kim, Bo-Guen
    Jhun, Byung Woo
    Kim, Hojoong
    Kwon, O. Jung
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease
    Thomson, Rachel M.
    Armstrong, John G.
    Looke, David F.
    CHEST, 2007, 131 (04) : 1166 - 1172
  • [48] Natural History of Mycobacterium Avium Complex Pulmonary Disease According to Disease Severity
    Kim, B.
    Kim, H.
    Kwon, O.
    Jhun, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
    Bo-Guen Kim
    Byung Woo Jhun
    Hojoong Kim
    O Jung Kwon
    Scientific Reports, 12
  • [50] Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease
    Yamada, Katsuo
    Seki, Yukio
    Nakagawa, Taku
    Hayashi, Yuta
    Yagi, Mitsuaki
    Ogawa, Kenji
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2019, 67 (04) : 363 - 369
12345